Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug

Longbing Ling; Muhammad Ismail; Yawei Du; Chen Yao; Xinsong Li

doi:10.1016/j.ijpharm.2019.02.007

journal article Apr 01, 2019

Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug

Longbing Ling Muhammad Ismail

Yawei Du

Chen Yao

Xinsong Li

International Journal of Pharmaceutics Vol. 560 pp. 246-260 · Elsevier BV

View at Publisher Save 10.1016/j.ijpharm.2019.02.007

Topics

No keywords indexed for this article. Browse by subject →

References

73

[1]

Al-Ahmady "Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo" ACS Nano (2012) 10.1021/nn302148p

[2]

Al-Majed "Alpha-lipoic acid ameliorates myocardial toxicity induced by doxorubicin" Pharmacol. Res. (2002) 10.1016/s1043661802002311

[3]

Liposomal drug delivery systems: From concept to clinical applications

Pieter R. Cullis

Advanced Drug Delivery Reviews 2013 10.1016/j.addr.2012.09.037

[4]

Alshehri "Carbon nanotubes in biomedical applications: factors, mechanisms, and remedies of toxicity" J. Med. Chem. (2016) 10.1021/acs.jmedchem.5b01770

[5]

Arivazhagan "Effect of DL-alpha-lipoic acid on the status of lipid peroxidation and lipids in aged rats" J. Gerontol. Series A, Biological Sci. Med. Sci. (2003) 10.1093/gerona/58.9.b788

[6]

Balakirev "Lipoic acid-derived amphiphiles for redox-controlled DNA delivery" Chem. Biol. (2000) 10.1016/s1074-5521(00)00030-2

[7]

Bast "Lipoic acid: a multifunctional antioxidant" NATO Sci. Series, Series I: Life Behav. Sci. (2002)

[8]

Bilal "Macromolecular agents with antimicrobial potentialities: a drive to combat antimicrobial resistance" Int. J. Biol. Macromolecules (2017) 10.1016/j.ijbiomac.2017.05.071

[9]

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Elvin Blanco, Haifa Shen, Mauro Ferrari

Nature Biotechnology 2015 10.1038/nbt.3330

[10]

Bogner "Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma" J. Acquired Immune Deficiency Syndromes (1994)

[11]

Boulikas "Liposomally-encapsulated cisplatin (Lipoplatin) plus gemcitabine in NSCLC: preliminary results of a phase II trial and its antiangiogenesis potential" J. Clin. Oncol. (2008) 10.1200/jco.2008.26.15_suppl.19024

[12]

Brzezinski "Nanoparticles from supramolecular polylactides overcome drug resistance of cancer cells" Eur. Polymer J. (2018) 10.1016/j.eurpolymj.2018.08.060

[13]

Ceh "Stealth liposomes: from theory to product" Adv. Drug Del. Reviews (1997) 10.1016/s0169-409x(96)00456-5

[14]

Chen "Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery" J. Am. Chem. Soc. (2008) 10.1021/ja805570f

[15]

Chen "Self-reporting liposomes for intracellular drug release" Small (2014) 10.1002/smll.201302698

[16]

Cheng "Bioresponsive polymeric nanotherapeutics for targeted cancer chemotherapy" Nano Today (2015) 10.1016/j.nantod.2015.09.005

[17]

Cho "Therapeutic nanoparticles for drug delivery in cancer" Clin. Cancer Res. (2008) 10.1158/1078-0432.ccr-07-1441

[18]

Deng "Reduction-sensitive polymeric nanocarriers in cancer therapy: a comprehensive review" Nanoscale (2015) 10.1039/c5nr02878g

[19]

Dong "Nanomedicinal strategies to treat multidrug-resistant tumors: current progress" Nanomedicine (London, United Kingdom) (2010) 10.2217/nnm.10.35

[20]

El-Sawy "Stimuli-responsive nano-architecture drug-delivery systems to solid tumor micromilieu: past, present, and future perspectives" ACS Nano (2018) 10.1021/acsnano.8b06104

[21]

Farzaneh "A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: from liposomal preparation to therapy" Int. J. Pharm. (Amsterdam, Netherlands) (2018)

[22]

Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies

May Freag, Yosra Elnaggar, Doaa Abdelmonsif et al.

International Journal of Nanomedicine 2016 10.2147/ijn.s111736

[23]

Gabizon "Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies" Clin. Pharmacokinetics (2003) 10.2165/00003088-200342050-00002

[24]

Goldenbogen "Reduction-sensitive liposomes from a multifunctional lipid conjugate and natural phospholipids: reduction and release kinetics and cellular uptake" Langmuir (2011) 10.1021/la201160y

[25]

Goraca "Lipoic acid – biological activity and therapeutic potential" Pharmacol. Rep. (2011) 10.1016/s1734-1140(11)70600-4

[26]

Guo "Chemical approaches to triggerable lipid vesicles for drug and gene delivery" Accounts Chem. Res. (2003) 10.1021/ar9703241

[27]

Hadjidemetriou "Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles" Nanoscale (2016) 10.1039/c5nr09158f

[28]

Homayoni "Combination of photodynamic therapy and nanotechnology: non-invasive weapon against cancer" Rev. Nanosci. Nanotechnol. (2014) 10.1166/rnn.2014.1050

[29]

Hosseini "Delivery of doxorubicin using double-layered core-shell nanocarrier based on magnetic Fe3O4 core and salep shells" Langmuir (2018) 10.1021/acs.langmuir.8b02390

[30]

Hu "Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines" Biomaterials (2018) 10.1016/j.biomaterials.2018.08.015

[31]

Huang "Disterolphospholipids: nonexchangeable lipids and their application to liposomal drug delivery" Angewandte Chemie, International Edition (2009) 10.1002/anie.200900111

[32]

Hubbell Jeffrey "Chemistry. Nanomaterials for drug delivery" Science (New York, N.Y.) (2012) 10.1126/science.1219657

[33]

Kievit Forrest "Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers" Adv. Mater. (Deerfield Beach, Fla.) (2011) 10.1002/adma.201102313

[34]

Laginha "Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors" Clin. Cancer Res. (2005) 10.1158/1078-0432.ccr-05-0343

[35]

Li "Multistage nanovehicle delivery system based on stepwise size reduction and charge reversal for programmed nuclear targeting of systemically administered anticancer drugs" Adv. Funct. Mater. (2015) 10.1002/adfm.201501248

[36]

Lim "Recent advances in pH-sensitive polymeric nanoparticles for smart drug delivery in cancer therapy" Curr. Drug Targets (2018) 10.2174/1389450117666160602202339

[37]

Linderoth "Mechanistic study of the sPLA2-mediated hydrolysis of a thio-ester pro anticancer ether lipid" J. Am. Chem. Soc. (2009) 10.1021/ja901412j

[38]

Ling "Assembled liposomes of dual podophyllotoxin phospholipid: preparation, characterization and in vivo anticancer activity" Nanomedicine (2017) 10.2217/nnm-2016-0396

[39]

Liu "pH-Responsive nanoemulsions for controlled drug release" Biomacromolecules (2014) 10.1021/bm4018484

[40]

Liu "Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity" Mole. Pharm. (2014) 10.1021/mp5000373

[41]

Luo "Short drug-light intervals improve liposomal chemophototherapy in mice bearing MIA PaCa-2 xenografts" Mole. Pharm. (2018) 10.1021/acs.molpharmaceut.8b00052

[42]

Mano "Stimuli-responsive polymeric systems for biomedical applications" Adv. Eng. Mater. (2008) 10.1002/adem.200700355

[43]

Metastasis: a question of life or death

Patrick Mehlen, Alain Puisieux

Nature Reviews Cancer 2006 10.1038/nrc1886

[44]

Meka "Peptide-directed liposomal delivery improves the therapeutic index of an immunomodulatory cytokine in controlling autoimmune arthritis" J. Controlled Release (2018) 10.1016/j.jconrel.2018.08.007

[45]

Mostafa "Protective effect of aminoguanidine against cardiovascular toxicity of chronic doxorubicin treatment in rats" Res. Commun. Mole. Pathol. Pharmacol. (1999)

[46]

Mura "Stimuli-responsive nanocarriers for drug delivery" Nat. Mater. (2013) 10.1038/nmat3776

[47]

Ong "Redox-triggered contents release from liposomes" J. Am. Chem. Soc. (2008) 10.1021/ja8050469

[48]

Prasad "Nanotherapeutics: an insight into healthcare and multi-dimensional applications in medical sector of the modern world" Biomed. Pharm. (2018) 10.1016/j.biopha.2017.11.026

[49]

Rasheed "Biomedical potentialities of taraxacum officinale-based nanoparticles biosynthesized using methanolic leaf extract" Curr. Pharm. Biotechnol. (2017) 10.2174/1389201019666180214145421

[50]

Raza "Redox-responsive nano-carriers as tumor-targeted drug delivery systems" Eur. J. Med. Chem. (2018) 10.1016/j.ejmech.2018.08.034

Showing 50 of 73 references

Metrics

28

Citations

73

References

Details

Published: Apr 01, 2019
Vol/Issue: 560
Pages: 246-260
License: View

Authors

Department of Computer Science, Tennessee Tech University, Cookeville, TN, USA

Y

Yawei Du

School of Architecture, Tianjin University, Tianjin 300072, China; Department of Management in the Built Environment, Faculty of Architecture and the Built Environment, Delft University of Technology, Julianalaan 134, 2628 BL Delft, The Netherlands

Funding

National Natural Science Foundation of China Award: 51373034

Cite This Article

Longbing Ling, Muhammad Ismail, Yawei Du, et al. (2019). Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug. International Journal of Pharmaceutics, 560, 246-260. https://doi.org/10.1016/j.ijpharm.2019.02.007

Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug

You May Also Like